Psychiatry

 
A Family Physician on How to Connect Patients to Mental Health Resources in the Community
September 10, 2025

Family physician Teresa Lovins, MD, highlights key community mental health resources primary care clinicians should know to support patients in crisis.

A Family Physician on When to Manage Depression in Primary Care—and When to Refer
September 09, 2025

Family physician Teresa Lovins, MD, explains how primary care clinicians can determine when to manage depression and when urgent referral is needed.

Teresa Lovins, MD: Primary Care Tools for Screening Mood and Behavioral Disorders
September 08, 2025

Teresa Lovins, MD, describes the PHQ-9, GAD-7, and other brief screeners that help family physicians identify depression, anxiety, ADHD, and bipolar disorder in everyday practice.

Spotting the Subtle Signs of Depression: How Familiarity Helps Family Physicians Excel, With Teresa Lovins, MD
August 29, 2025

Primary care clinicians see a higher share of visits for depression than mental health professionals largely because they know their patients so well, Lovins said.

Brief Suicide Screening in Primary Care Cut Risk by 25%: Family Physician Highlights NIMH Study
August 28, 2025

Teresa Lovins, MD, highlights a study that showed a 14% increase in rates of safety planning within 2 weeks of a negative screening led to a 25% decrease in attempted suicides.

A Family Physician Explains Why Primary Care Can't Afford to Miss Signs of Suicide Risk
August 27, 2025

Teresa Lovins, MD, sees at least 1 or 2 patients a week who have suicidal ideation. Too many of them are at risk for an attempt within a month of those visits.

Family Medicine is Where Mental Health Care Starts, With Teresa Lovins, MD
August 26, 2025

Mental health issues affect half the population at some point during a lifetime. Teresa Lovins, MD, says FPs are often the first to learn that "something is going on."

NeuroStim Announces Single-Day TMS Protocol With High Remission Rates in Depression
August 26, 2025

One-Day TMS condenses transcranial magnetic stimulation therapy treatment from a daily month-long process to 1 day, with rapid and durable results, NeuroStim says.

Risk of Major Depressive Disorder Spikes Following a Medical Diagnosis, Endures for Decades: New Data
August 20, 2025

The risk for MDD is greatest in the first month after diagnosis and the absolute risk remains elevated even 20 years later, making early detection and treatment imperative.

Investigational Psychedelic RE104 for Postpartum Depression Delivers Positive Phase 2 Results: Reunion Neuroscience Update
August 18, 2025

In the RE104 group receiving the 30-mg dose, clinically meaningful reductions in the primary endpoint were seen on day 1 posttreatment and sustained through day 28 follow-up.